News and Press Releases RSS feed



BOSTON, Mass. - The United States has reached a civil settlement with a Georgetown pharmacy and its owner in connection with civil drug diversion allegations.

Georgetown Pharmacy and its owner, Joseph Lamonica, have agreed to pay $40,000 in settlement of the government’s claims. Based on facts developed in the course of the investigation, the United States contended that Georgetown Pharmacy violated the Controlled Substances Act by distributing methadone, a Schedule II painkiller subject to strict regulatory handling and record-keeping requirements, to a medical facility that was not registered with the DEA as a Narcotic Treatment Program, and by failing to maintain proper records and inventories with respect to methadone in the pharmacy’s possession.

"Controlled substances that are handled by pharmacies are subject to strict requirements because of their potential for harm and abuse," stated U.S. Attorney Carmen M. Ortiz. "This office takes the mishandling of prescription drugs extremely seriously, and will continue to seek all appropriate remedies to ensure that pharmacies and providers abide by their obligations in handling these powerful drugs."

U.S. Attorney Ortiz and Steven W. Derr, Special Agent in Charge of the Drug Enforcement Administration, New England Field Division, made the announcement today. The investigation was conducted by Diversion Investigators with the DEA's New England Field Division as well as investigators from the Massachusetts Department of Public Health. The case was handled by Assistant U.S. Attorney Christine J. Wichers of Ortiz’s Civil Division.



Return to Top